BAXTER HEALTHCARE CORPORATION for BAXTER HEALTHCARE CORPORATION
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to pharmaceutical pricing; Legislation to incentivize new technology for innovation in home dialysis (no current bill number).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK COIN | — |
| CHRISTOPHER LEIBUNDGUTH | — |
Budget/Appropriations BUD
Issues related to increasing funding for Strategic National Stockpile. Labor, Health, and Human Services appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CADE CLURMAN | — |
| MARK COIN | — |
| CHRISTOPHER LEIBUNDGUTH | — |
| JACK MANIKO | — |
| JOSEPH V SCHWAN | — |
Taxation/Internal Revenue Code TAX
Taxation of multinational companies. Monitor tax reform proposal relating to corporate tax policies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CADE CLURMAN | — |
| JOSEPH V SCHWAN | — |
Health Issues HCR
Issues relating to drug pricing, home dialysis expansion, ESRD reimbursement for Hemodialysis, 340B Drug pricing, device sterilization. Issues relating to safe mobility and issues relating to diabetic retinopathy. Issues relating to pandemic preparedness act. H. Res. 550 and H.R. 4421. Issues related to artificial intelligence technology in healthcare.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CADE CLURMAN | — |
| MARK COIN | — |
| CHRISTOPHER LEIBUNDGUTH | — |
| JACK MANIKO | — |
| JOSEPH V SCHWAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.